Healthcare Companies Push for Passage of MEDTECH Act | Healthcare Informatics Magazine | Health IT | Information Technology Skip to content Skip to navigation

Healthcare Companies Push for Passage of MEDTECH Act

February 22, 2016
by Rajiv Leventhal
| Reprints

Several prominent healthcare organizations have signed a letter to Sens. Lamar Alexander (R-Tenn.) and Patty Murray (D-Wash.) that calls for the passage of a bill that aims to boost innovation in health IT by exempting low-risk medical software and mobile apps from regulatory oversight.

Late in 2014, U.S. Senators Michael Bennet (D-CO) and Orrin Hatch (R-UT) originally introduced the Medical Electronic Data Technology Enhancement for Consumers’ Health (MEDTECH) Act, S. 1101, that aims to cut red tape at the Food and Drug Administration (FDA) in terms of regulatory oversight of health IT software products. The bill would exempt low-risk medical software and mobile apps from the FDA regulation. It would also clarify which software would be regulated by the agency to protect consumers. The bill was then referred to the Senate Committee for Health Education Labor and Pensions (HELP).

Now, the letter to Alexander and Murray, Senate HELP Chairman and Ranking Member, respectively, penned by major vendors such as athenahealth, IBM, McKesson, and other healthcare companies, says, “Within the broad community of stakeholders, there is near universal agreement that regulatory certainty is essential for continued innovation and development of health IT. We are concerned, however, that significant confusion exists in the market place about what technologies may be regulated, by which agencies, and to what standard.”

It continues, “This uncertainty creates barriers to the development of promising technologies that can help clinicians access more evidence-based medicine, provide patient populations with specific needs more individualized care, and generate better patient-caregiver-provider engagement. The potential cost and delay created by current regulatory uncertainty may further deter software and system developers from creating products that have the ability to greatly benefit patients.”

The letter concludes, “We are pleased to see the bipartisan support for S. 1101 and we encourage the Committee to pass this crucial piece of legislation. Congressional action on this issue will allow the Administration to focus its limited resources, staff and expertise on ensuring the safety of new medical technologies that pose the highest potential risk to patients, and will promote a new era of medical innovation that will improve care and lower costs.”

Topics

News

Former Michigan Governor to Serve as Chair of DRIVE Health

Former Michigan Governor John Engler will serve as chair of the DRIVE Health Initiative, a campaign aimed at accelerating the U.S. health system's transition to value-based care.

NJ Medical Group Launches Statewide HIE, OneHealth New Jersey

The Medical Society of New Jersey (MSNJ) recently launched OneHealth New Jersey, a statewide health information exchange (HIE) that is now live.

Survey: 70% of Providers Using Off-Premises Computing for Some Applications

A survey conducted by KLAS Research found that 70 percent of healthcare organizations have moved at least some applications or IT infrastructure off-premises.

AMIA Warns of Tax Bill’s Impact on Graduate School Programs in Informatics

Provisions in the Republican tax bill that would count graduate student tuition waivers as taxable income would have detrimental impacts on the viability of fields such as informatics, according to the American Medical Informatics Association.

Appalachia Project to Study Relationship Between Increased Broadband Access, Improved Cancer Care

The Federal Communications Commission and the National Cancer Institute have joined forces to focus on how increasing broadband access and adoption in rural areas can improve the lives of rural cancer patients.

Survey: By 2019, 60% of Medicare Revenues will be Tied to Risk

Medical groups and health systems that are members of AMGA (the American Medical Group Association) expect that nearly 60 percent of their revenues from Medicare will be from risk-based products by 2019, according to the results from a recent survey.